Bioabsorbable heart valves or blood vessels are designed to harness the body’s innate healing process, enabling the natural restoration of complex body parts as the synthetic graft is absorbed.
The TRANSFORM trial was designed to evaluate the safety and performance of an investigational rapid deployment aortic valve replacement (RDAVR) system for patients with severe aortic stenosis.
May 18, 2016 — The Intersocietal Accreditation Commission (IAC) recently announced its launch of the IAC QI Self ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
NeoChord Inc. announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a prospective, multicenter, randomized clinical trial for its Artificial Chordae Delivery System, DS1000.
Biotronik presented 12-month data from the BIOSOLVE-II trial during a Hotline Session at EuroPCR 2016.
Science fiction offers a lot of ideas for creating new body parts on demand, and the advancement of 3-D printing (also ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 17, 2016 — An interdisciplinary Johns Hopkins University team has developed a non-invasive 3-D virtual heart ...
Macadamian Technologies, a user experience research, design and software development firm, recently announced the completion of a comprehensive usability test of Siemens Acuson S3000 ultrasound system, HELX Evolution with Touch Control.
The U.S. Department of Health and Human Services (HHS) released two funding opportunities from the Office of the National Coordinator for Health Information Technology (ONC), designed to expand use of common standards supporting the sharing of health information.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
4Tech Inc. announced its partnership with Jean-Claude Laborde, M.D., as a research and development (R&D) and clinical advisor focused on fast-forwarding the TriCinch Generation Two and Generation Three programs.
At the 96th American Association for Thoracic Surgery (AATS) Annual Meeting, investigators presented the results of a long-term study of patients who underwent mitral valve (MV) repair.
May 16, 2016 — The largest observational study of percutaneous transfemoral transcatheter aortic valve replacement (TAVR ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 16, 2016 — Cardinal Health announced it has entered into a distribution agreement with Biosensors that enables ...
May 16, 2016 – To work towards a better method of diagnosis and treatment of congestive heart failure (CHF), Peter ...
May 16, 2016 — Patients treated with processed autologous adipose-derived regenerative cells (ADRCs) injected into the ...